Chemotherapy Effects is an indication for drug development with over 200 pipeline drugs currently active. According to GlobalData, preregistered drugs for Chemotherapy Effects have a 76.32% likelihood of approval (LoA) indication benchmark. GlobalData’s report assesses how phase transition success rate (PTSR) and likelihood of approval (LoA) scores for pipeline drugs in Chemotherapy Effects compared to historical benchmarks. Buy the report here.
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Chemotherapy Effects overview
Chemotherapy effects are the unwanted effects that can be seen after taking chemotherapeutic drugs. It can cause fatigue, loss of appetite, nausea, bowel issues such as constipation or diarrhoea, hair loss, mouth sores, skin and nail problems.
For a complete picture of PTSR and LoA scores for drugs in Chemotherapy Effects, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.